{"id":"lutinus-transfer-day-6","safety":{"commonSideEffects":[{"rate":null,"effect":"Vaginal irritation or discharge"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Breast tenderness"},{"rate":null,"effect":"Abdominal discomfort"}]},"_chembl":{"chemblId":"CHEMBL1298","moleculeType":"Small molecule","molecularWeight":"440.58"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Lutinus (micronized progesterone) provides exogenous progesterone to supplement endogenous production during the luteal phase after ovulation or embryo transfer. Progesterone is essential for endometrial preparation and maintenance of early pregnancy by promoting secretory changes in the uterus and suppressing uterine contractions. The 'transfer day 6' designation indicates use as luteal phase support beginning 6 days after embryo transfer in in vitro fertilization (IVF) protocols.","oneSentence":"Lutinus is a progesterone supplement used to support luteal phase function and embryo implantation during assisted reproductive technology cycles.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:41:17.240Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Luteal phase support in assisted reproductive technology (ART) / in vitro fertilization (IVF) cycles"},{"name":"Embryo implantation support after embryo transfer"}]},"trialDetails":[{"nctId":"NCT03795220","phase":"PHASE4","title":"Preparing and Timing of the Endometrium in Modified Natural Cycle Frozen-thawed Embryo Transfers","status":"COMPLETED","sponsor":"Anja Bisgaard Pinborg","startDate":"2019-01-06","conditions":"Infertility","enrollment":679}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Lutinus"],"phase":"marketed","status":"active","brandName":"Lutinus + transfer day 6","genericName":"Lutinus + transfer day 6","companyName":"Anja Bisgaard Pinborg","companyId":"anja-bisgaard-pinborg","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Lutinus is a progesterone supplement used to support luteal phase function and embryo implantation during assisted reproductive technology cycles. Used for Luteal phase support in assisted reproductive technology (ART) cycles, Progesterone supplementation after embryo transfer on day 6.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}